Harold H. Shlevin, Chief Operating Officer at GALECTIN THERAPEUTICS INC (GALT), sold 210,860 shares at $5.21 ($1.1M) on 2018-06-07, disclosed to the SEC on 2018-06-08.
Open-market sale of $1.1M GALT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.15 | 9,078 | $47K | 4.3% |
| 2 | $5.21 | 100,891 | $526K | 47.9% |
| 3 | $5.21 | 100,891 | $526K | 47.9% |
| Total | $5.21 avg | 210,860 | $1.1M | 100% |
| Filing → |
| GALT | SELL | 2025-12-16 | $354K | — | Filing → |
| GALT | SELL | 2025-12-10 | $1.3M | — | Filing → |
| GALT | BUY | 2024-12-31 | $8K | — | Filing → |